Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07759206
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of MinnesotaCompletedNot Applicable
NCT07759206Completed
Not Applicable
Gentle Skin Abrasion and EMG-Based Neuromuscular Blockade MonitoringUniversity of Minnesota
NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFAstraZenecaNot Yet RecruitingPhase 3
NCT07761117Not Yet Recruiting
Phase 3
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Ad...AstraZeneca
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted BronchoscopyIntuitive SurgicalNot Yet RecruitingPhase 4
NCT07761351Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-...Intuitive Surgical
NCT07761377
Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CTTaichung Veterans General HospitalRecruiting
NCT07761377Recruiting
—
Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis...Taichung Veterans General...
NCT07759128
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderOtsuka Pharmaceutical Development & Commercialization, Inc.RecruitingPhase 3
NCT07759128Recruiting
Phase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...Otsuka Pharmaceutical Dev...
NCT07760649
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic StrokeNeuravi LimitedNot Yet Recruiting
NCT07760649Not Yet Recruiting
—
A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in t...Neuravi Limited
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07761806
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams UniversityCompletedPhase 2
NCT07761806Completed
Phase 2
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams University
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Disease Research in ZambiaSuspended
NCT07760324Suspended
—
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Dis...
NCT07760506
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic HealthApplied Science & Performance InstituteNot Yet RecruitingNot Applicable
NCT07760506Not Yet Recruiting
Not Applicable
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting...Applied Science & Perform...
NCT07759362
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics CompanyNot Yet RecruitingPhase 3
NCT07759362Not Yet Recruiting
Phase 3
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT...Endo USA Inc., a Keenova...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759726
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab UniversityCompletedNot Applicable
NCT07759726Completed
Not Applicable
Cellphone Access for Lowered Maternal Anxiety and Stress in Cesarean SectionsBeirut Arab University
NCT07761559
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness and Consumption Among University StudentsBENGİSU KARAGÖZActive Not RecruitingNot Applicable
NCT07761559Active Not Recruiting
Not Applicable
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness a...BENGİSU KARAGÖZ
NCT07761247
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye UniversityNot Yet RecruitingNot Applicable
NCT07761247Not Yet Recruiting
Not Applicable
Dual-Task Neuromuscular Warm-Up Exercises in Chronic Low Back PainIstinye University
NCT07759297
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac SurgeryShusheng LiCompleted
NCT07759297Completed
—
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac Surg...Shusheng Li
NCT07761650
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital LahoreCompletedNot Applicable
NCT07761650Completed
Not Applicable
Comparison of CT-Guided Celiac Plexus Neurolysis and PharmacotherapyMayo Hospital Lahore
NCT07761052
The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scale a Culturally-Adapted and Evidence-Based Intervention for Latino FamiliesNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07761052Not Yet Recruiting
Not Applicable
The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scal...National Institute of Men...
Result Breakdown
Not yet recruiting8 (40%)
Completed7 (35%)
Recruiting3 (15%)
Suspended1 (5%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 33 (15%)
Phase 22 (10%)
Phase 41 (5%)